Integral Health Asset Management as of June 30, 2022
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 65 positions in its portfolio as reported in the June 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Anthem (ELV) | 6.7 | $33M | 68k | 482.58 | |
Centene Corporation (CNC) | 6.1 | $30M | 350k | 84.61 | |
Eli Lilly & Co. (LLY) | 4.9 | $24M | 73k | 324.23 | |
Cytokinetics Com New (CYTK) | 4.2 | $21M | 525k | 39.29 | |
Sanofi Sponsored Adr (SNY) | 3.6 | $18M | 350k | 50.03 | |
Guardant Health (GH) | 3.2 | $16M | 385k | 40.34 | |
Astrazeneca Sponsored Adr (AZN) | 3.2 | $16M | 235k | 66.07 | |
Envista Hldgs Corp (NVST) | 3.1 | $15M | 386k | 38.54 | |
Chemocentryx | 2.9 | $14M | 574k | 24.78 | |
McKesson Corporation (MCK) | 2.8 | $14M | 42k | 326.22 | |
Sage Therapeutics (SAGE) | 2.7 | $13M | 412k | 32.30 | |
Tenet Healthcare Corp Com New (THC) | 2.7 | $13M | 251k | 52.56 | |
CVS Caremark Corporation (CVS) | 2.7 | $13M | 141k | 92.66 | |
Dex (DXCM) | 2.6 | $12M | 167k | 74.53 | |
BioMarin Pharmaceutical (BMRN) | 2.2 | $11M | 126k | 82.87 | |
PerkinElmer (RVTY) | 2.0 | $9.6M | 68k | 142.22 | |
Zentalis Pharmaceuticals (ZNTL) | 2.0 | $9.6M | 340k | 28.10 | |
Merck & Co (MRK) | 2.0 | $9.5M | 104k | 91.17 | |
Shockwave Med | 1.8 | $9.0M | 47k | 191.16 | |
Kura Oncology (KURA) | 1.7 | $8.5M | 461k | 18.33 | |
Alkermes SHS (ALKS) | 1.6 | $7.8M | 262k | 29.79 | |
Amicus Therapeutics (FOLD) | 1.6 | $7.6M | 705k | 10.74 | |
Perrigo SHS (PRGO) | 1.5 | $7.4M | 183k | 40.57 | |
Relay Therapeutics (RLAY) | 1.5 | $7.3M | 436k | 16.75 | |
Alnylam Pharmaceuticals (ALNY) | 1.4 | $6.9M | 47k | 145.85 | |
Icon SHS (ICLR) | 1.4 | $6.8M | 31k | 216.70 | |
Uniqure Nv SHS (QURE) | 1.4 | $6.6M | 353k | 18.64 | |
Blueprint Medicines (BPMC) | 1.4 | $6.6M | 130k | 50.51 | |
Irhythm Technologies (IRTC) | 1.3 | $6.2M | 57k | 108.03 | |
1life Healthcare | 1.2 | $5.7M | 731k | 7.84 | |
Moderna (MRNA) | 1.2 | $5.7M | 40k | 142.85 | |
Seagen | 1.1 | $5.5M | 31k | 176.93 | |
Zai Lab Adr (ZLAB) | 1.1 | $5.4M | 157k | 34.68 | |
Agilon Health (AGL) | 1.0 | $5.0M | 231k | 21.83 | |
Crispr Therapeutics Namen Akt (CRSP) | 1.0 | $4.9M | 80k | 60.77 | |
Apellis Pharmaceuticals (APLS) | 0.9 | $4.5M | 99k | 45.22 | |
Intra Cellular Therapies (ITCI) | 0.9 | $4.5M | 78k | 57.08 | |
Zimmer Holdings (ZBH) | 0.9 | $4.4M | 42k | 105.06 | |
Intellia Therapeutics (NTLA) | 0.9 | $4.3M | 84k | 51.76 | |
Ptc Therapeutics I (PTCT) | 0.9 | $4.2M | 105k | 40.06 | |
DaVita (DVA) | 0.9 | $4.2M | 52k | 79.97 | |
Teladoc (TDOC) | 0.8 | $4.1M | 124k | 33.21 | |
Aclaris Therapeutics (ACRS) | 0.8 | $4.0M | 286k | 13.96 | |
Replimune Group (REPL) | 0.8 | $3.8M | 219k | 17.48 | |
Mirum Pharmaceuticals (MIRM) | 0.7 | $3.5M | 177k | 19.46 | |
Nevro (NVRO) | 0.7 | $3.4M | 78k | 43.83 | |
Krystal Biotech (KRYS) | 0.7 | $3.4M | 52k | 65.65 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.7 | $3.3M | 21k | 156.03 | |
Iteos Therapeutics (ITOS) | 0.7 | $3.2M | 157k | 20.60 | |
Reata Pharmaceuticals Cl A | 0.7 | $3.2M | 104k | 30.39 | |
Xenon Pharmaceuticals (XENE) | 0.6 | $3.0M | 97k | 30.42 | |
Heron Therapeutics (HRTX) | 0.6 | $2.8M | 1.0M | 2.79 | |
Akero Therapeutics (AKRO) | 0.6 | $2.7M | 288k | 9.45 | |
Arcturus Therapeutics Hldg I (ARCT) | 0.5 | $2.5M | 157k | 15.74 | |
Nanostring Technologies (NSTGQ) | 0.5 | $2.4M | 189k | 12.70 | |
Kiniksa Pharmaceuticals Com Cl A | 0.5 | $2.3M | 235k | 9.69 | |
Lifestance Health Group (LFST) | 0.4 | $2.1M | 376k | 5.56 | |
Si-bone (SIBN) | 0.4 | $2.1M | 157k | 13.20 | |
Insmed Com Par $.01 (INSM) | 0.4 | $2.1M | 104k | 19.72 | |
Atara Biotherapeutics | 0.3 | $1.6M | 209k | 7.79 | |
Forma Therapeutics Hldgs SHS | 0.2 | $896k | 130k | 6.89 | |
Cincor Pharma | 0.2 | $787k | 42k | 18.85 | |
Lexicon Pharmaceuticals Com New (LXRX) | 0.1 | $558k | 300k | 1.86 | |
Magenta Therapeutics | 0.1 | $394k | 328k | 1.20 | |
Longboard Pharmaceuticals In (LBPH) | 0.0 | $177k | 57k | 3.09 |